Moreover, lncRNAs can regulate lipid metabolism to influence fat deposition, for example, the lncRNA-SRA limits adipose triglyceride lipase promoter activity in hepatic steatosis primarily by inhibiting forkhead box protein O1 (FoxO1) expression [35]. Here, FOXO1 is linked to fatty liver disease.